300639.SZ

Guangdong Hybribio Biotech Co.,Ltd. [300639.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

300639.SZ Stock Summary

Top 300639.SZ Correlated Resources

300639.SZ

Top 10 Correlated ETFs

300639.SZ

Top 10 Correlated Stocks

300639.SZ

In the News

300639.SZ Financial details

Company Rating
-
Market Cap
4.36B
Income
390.35M
Revenue
2.19B
Book val./share
-
Cash/share
-
Dividend
0.35
Dividend %
4.05%
Employees
3.34K
Optionable
No
Shortable
Yes
Earnings
25 Oct 2023
P/E
9.68
Forward P/E
-
PEG
-1.79
P/S
2.55
P/B
0.77
P/C
-
P/FCF
-29.09
Quick Ratio
4.27
Current Ratio
4.57
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.6
EPS next Y
-
EPS next Q
-
EPS this Y
103.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
69.39%
Revenue last 5Y
57.34%
Revenue Q/Q
-19.88%
EPS Q/Q
-14.29%
-
-
-
-
SMA20
-16.67%
SMA50
-16.67%
SMA100
-28.57%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
8%
ROC
0.07%
Gross Margin
68%
Oper. Margin
16%
Profit Margin
18%
Payout
42%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.65-11.873333
52W High
-53.64%
52W Low
+2%
RSI
43
Rel Volume
0.74
Avg Volume
6.23M
Volume
4.6M
Perf Week
-0.78%
Perf Month
-16.26%
Perf Quarter
-17.48%
Perf Half Y
-22.14%
-
-
-
-
Beta
0.479
-
-
Volatility
0.05%, 0.34%
Prev Close
0%
Price
5.1
Change
-0.58%

300639.SZ Financial Performance

300639.SZ Dividend History

300639.SZ Frequently Asked Questions

What is Guangdong Hybribio Biotech Co.,Ltd. stock symbol ?

Guangdong Hybribio Biotech Co.,Ltd. is a HK stock and trading under the symbol 300639.SZ

What is Guangdong Hybribio Biotech Co.,Ltd. stock quote today ?

Guangdong Hybribio Biotech Co.,Ltd. stock price is $5.1 today.

Is Guangdong Hybribio Biotech Co.,Ltd. stock public?

Yes, Guangdong Hybribio Biotech Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
BRK-B
VTI
TL0.DE
VOO
BRK-A
Top Correlated ETFs
CWEB
WBIG
HHL.TO
BOUT
PTIN
Top Correlated Stocks
002030.SZ
002382.SZ
002939.SZ
000028.SZ
300168.SZ
Similar Market Cap
600984.SS
603867.SS
FHI
VTSC.DE
JTSCX

Company Profile

Healthcare Medical - Diagnostics & Research
  • Volume Average 6.23M
  • Market Capitalization 4.36B
  • Employee 3.34K
  • CEO Ms. Jianyu Wang
  • Headquarters Sheung Wan,HK
  • IPO Date 2017-04-13
  • Website https://www.hybribio.cn

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.